For Adverse Event reporting, please contact Pharmacovigilance department via:
Tel: (+30) 210-6039326 (24hour phone line)
Fax: (+30) 210-6039300
E-mail: pharmacovigilance@elpen.gr
Thank you for contacting ELPEN’s Pharmacovigilance department. The information provided in the content of Adverse Event reporting is treated with confidentiality and it is processed in line with the current legislation. In any case, you may maintain your anonymity.
In case of a Quality Complaint, please contact us via:
Tel: (+30) 210-6039326 (24hour phone line)
E-mail: complaints@elpen.gr
In case of a Medical query, please contact us via:
Tel: (+30) 210-6039326 (24hour phone line)
E-mail: medicalinfo@elpen.gr
For Online Orders please Sign In to the “ELPEN B2B” platform
You can access the platform using the following link: https://b2b.elpen.gr
For any further details please contact our Distribution department
Tel.: (+30) 211-1865 128, 211-1865 408, 211-1565 120, 211-1865 000
Ε-mail: distribution@elpen.gr
Please choose one of the following options and we will respond to your inquiry as quickly as possible:
ELPEN Pharmaceutical Co. Inc.
Headquarters:
95, Marathonos avenue
190 09 Pikermi - Attica, Greece
Tel: +30 210 6039326-9
Fax: +30 210 6039300
E-mail: info@elpen.gr
Research & Experimental Center
95, Marathonos avenue
190 09 Pikermi - Attica, Greece
Tel: 210 60 393 26-9
E-mail: experimental@elpen.gr
SCIENTIFIC INFORMATION OFFICES of Southern Greece
11, Sevastias Str.,
115 28 Athens, Greece
Tel: 210 74 88 711
Fax: 210 74 88 731
E-mail: neinfo@elpen.gr
SCIENTIFIC INFORMATION OFFICES Northern Greece
114, Athnikis Antistaseos Str
551 34 Thessaloniki, Greece
Tel: 2310 45 99 20-1
Fax: 2310 45 92 69
CONSUMER HEALTH CARE DEPARTMENT
41, Papadimantopoulou Str.,
115 28 Athens, Greece
Tel: 211 18 65 347
Fax: 211 18 65 173